Markel Group (MKL) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
2 Apr, 2026Executive summary
The annual meeting will be held on May 20, 2026, to elect directors, approve executive compensation, ratify the auditor, amend the Articles of Incorporation, and vote on two shareholder proposals.
Shareholders can vote via internet, phone, mail, or in person, with a record date of March 12, 2026, and 12,547,039 shares outstanding.
Proxy materials are available online, and householding procedures are in place to reduce environmental impact.
Voting matters and shareholder proposals
Proposals include electing 11 directors, advisory approval of executive compensation, ratification of KPMG LLP as auditor, amending the Articles to lower voting thresholds, and two shareholder proposals.
The Board recommends FOR all management proposals and AGAINST both shareholder proposals: one on environmental risk reporting and one to lower the threshold for calling special meetings.
The amendment to the Articles responds to a prior shareholder vote and would reduce supermajority requirements to a simple majority for key corporate actions.
Board of directors and corporate governance
The Board consists of 11 directors, with a mix of industry, financial, legal, and operational expertise.
9 of 11 nominees are independent; all Board committees are composed entirely of independent directors.
The Board has Audit, Compensation, and Nominating/Corporate Governance Committees, each with defined charters and annual self-evaluations.
The Board separates the roles of CEO and Chairman and designates a Lead Independent Director.
Proxy access allows shareholders owning at least 3% for three years to nominate directors.
Latest events from Markel Group
- Key votes include director elections, auditor ratification, and proposals on ESG and shareholder rights.MKL
Proxy filing2 Apr 2026 - Board recommends all management proposals and opposes both shareholder proposals at the 2026 meeting.MKL
Proxy Filing6 Mar 2026 - Operating income rose to $3.2B, with broad-based growth and improved insurance profitability.MKL
Q4 20255 Feb 2026 - H1 2024 revenues up 5%, but Q2 income fell on equity volatility and discontinued product losses.MKL
Q2 20242 Feb 2026 - Net income and operating income surged, with robust investment gains and ongoing share repurchases.MKL
Q3 202417 Jan 2026 - Operating income jumped 27% to $3.71B, with improved insurance and major share repurchases.MKL
Q4 20248 Jan 2026 - Key votes include director elections, auditor ratification, and ESG-related shareholder proposals.MKL
Proxy Filing1 Dec 2025 - Board recommends director slate, performance-based pay, and opposes GHG and voting proposals.MKL
Proxy Filing1 Dec 2025 - Q1 2025 saw lower profits from investment losses, but insurance and capital positions improved.MKL
Q1 202529 Nov 2025